Type 1 and type 2 diabetes, insulin resistance, glucose metabolism, and metabolic health
268 artigos
Breakthrough modulator therapies are changing how doctors diagnose and treat diabetes in cystic fibrosis patients worldwide.
Study shows adults under 35 achieve diabetes remission 3x faster than older patients following gastric bypass surgery.
New research reveals how adrenaline from hypoglycemia causes prolonged inflammatory responses lasting up to seven days.
Simple retinal scans combined with basic tests accurately identified mild cognitive impairment in 80% of diabetes patients.
New study reveals behavioral diet therapy improves glucose metabolism better than gastric bypass surgery despite equal weight loss.
Groundbreaking study reveals pancreatic fibrosis as a causal factor in diabetes development, opening new prevention pathways.
New research reveals how the popular weight loss drug semaglutide works differently across three phases of treatment.
New research reveals how specific gene combinations affect how quickly pre-diabetes advances to full type 1 diabetes.
New research reveals how the TUG protein traps glucose transporters, contributing to insulin resistance in fat tissue.
New research shows phosphatidylserine supplementation reduces liver fat and inflammation while improving glucose control through enhanced fat metabolism.
New research reveals how genetic predisposition to type 2 diabetes influences insulin function and disease progression in people developing type 1 diabetes.
Research spotlight reveals promising approaches to prevent diabetic neuropathy and stop Type 1 diabetes development.
